SALMA BALBAS: Open Payments
NPI 1194314104 · LOS ALAMITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,013 in 104 payments from 18 companies in 2025. Trend: 2023 $760 · 2024 $2,700 · 2025 $2,013
Food & beverage: $1,939Education: $74
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $675 |
| Janssen Biotech, Inc. | 10 | $266 |
| Regeneron Healthcare Solutions, Inc. | 6 | $199 |
| MAYNE PHARMA COMMERCIAL LLC | 21 | $154 |
| Galderma Laboratories, L.P. | 10 | $145 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $81 |
| Lilly USA, LLC | 3 | $73 |
| UCB, Inc. | 2 | $66 |
| PFIZER INC. | 2 | $54 |
| Amgen Inc. | 2 | $51 |
Products named: RINVOQ, TREMFYA, SKYRIZI, DUPIXENT, NEMLUVIO, TALTZ, Bimzelx, Winlevi.
Industry payments across CA — which companies pay providers there.
